Martin H. Bolli

2.6k total citations
54 papers, 1.9k citations indexed

About

Martin H. Bolli is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Martin H. Bolli has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 12 papers in Organic Chemistry and 9 papers in Physiology. Recurrent topics in Martin H. Bolli's work include DNA and Nucleic Acid Chemistry (16 papers), Sphingolipid Metabolism and Signaling (15 papers) and RNA and protein synthesis mechanisms (11 papers). Martin H. Bolli is often cited by papers focused on DNA and Nucleic Acid Chemistry (16 papers), Sphingolipid Metabolism and Signaling (15 papers) and RNA and protein synthesis mechanisms (11 papers). Martin H. Bolli collaborates with scholars based in Switzerland, United States and Germany. Martin H. Bolli's co-authors include Albert Eschenmoser, Christian J. Leumann, Ronald Micura, Markus Tarköy, Christoph Boss, Patrick Hess, Martine Clozel, Thomas Weller, John Gatfield and Oliver Nayler and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Martin H. Bolli

54 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin H. Bolli Switzerland 24 1.2k 351 341 291 264 54 1.9k
Xiangshu Xiao United States 27 1.3k 1.1× 548 1.6× 85 0.2× 47 0.2× 49 0.2× 66 2.1k
Jan Rosing Netherlands 21 1.2k 1.0× 66 0.2× 111 0.3× 169 0.6× 11 0.0× 43 2.1k
W. Schöner Germany 19 731 0.6× 22 0.1× 202 0.6× 68 0.2× 33 0.1× 52 1.2k
Kazuki Sakata Japan 18 272 0.2× 303 0.9× 89 0.3× 75 0.3× 8 0.0× 82 1.3k
Rozalina Grubina United States 9 747 0.6× 235 0.7× 48 0.1× 185 0.6× 5 0.0× 13 1.6k
G. Bernhardt Germany 17 461 0.4× 101 0.3× 87 0.3× 17 0.1× 31 0.1× 29 947
Mark S. Lowenthal United States 19 793 0.6× 29 0.1× 51 0.1× 27 0.1× 33 0.1× 41 1.3k
Glenn C. Andrews United States 25 1.2k 1.0× 954 2.7× 128 0.4× 81 0.3× 4 0.0× 39 2.7k
Robert J. Rutman United States 21 825 0.7× 146 0.4× 31 0.1× 48 0.2× 13 0.0× 61 1.4k
Hitoshi Fujita Japan 17 324 0.3× 198 0.6× 104 0.3× 10 0.0× 14 0.1× 66 925

Countries citing papers authored by Martin H. Bolli

Since Specialization
Citations

This map shows the geographic impact of Martin H. Bolli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin H. Bolli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin H. Bolli more than expected).

Fields of papers citing papers by Martin H. Bolli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin H. Bolli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin H. Bolli. The network helps show where Martin H. Bolli may publish in the future.

Co-authorship network of co-authors of Martin H. Bolli

This figure shows the co-authorship network connecting the top 25 collaborators of Martin H. Bolli. A scholar is included among the top collaborators of Martin H. Bolli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin H. Bolli. Martin H. Bolli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bolli, Martin H., et al.. (2024). Large-Scale Synthesis of LPA1-Receptor Antagonist ACT-1016-0707. Organic Process Research & Development. 28(2). 577–587. 3 indexed citations
2.
Birker, Magdalena, Martin H. Bolli, Markus Rey, et al.. (2017). S1P1 Modulator-Induced Gi Signaling and β-Arrestin Recruitment Are Both Necessary to Induce Rapid and Efficient Reduction of Blood Lymphocyte Count In Vivo. Molecular Pharmacology. 93(2). 109–118. 4 indexed citations
3.
Bolli, Martin H., Cyrille Lescop, Magdalena Birker, et al.. (2016). Novel S1P1 receptor agonists – Part 5: From amino-to alkoxy-pyridines. European Journal of Medicinal Chemistry. 115. 326–341. 12 indexed citations
4.
Lescop, Cyrille, Magdalena Birker, Ruben de Kanter, et al.. (2016). Novel S1P 1 receptor agonists – Part 4: Alkylaminomethyl substituted aryl head groups. European Journal of Medicinal Chemistry. 116. 222–238. 11 indexed citations
5.
Boss, Christoph, Martin H. Bolli, & John Gatfield. (2016). From bosentan (Tracleer®) to macitentan (Opsumit®): The medicinal chemistry perspective. Bioorganic & Medicinal Chemistry Letters. 26(15). 3381–3394. 23 indexed citations
6.
Dingemanse, Jasper, Martin H. Bolli, & Marc Iglarz. (2015). Treatment of obesity and pulmonary arterial hypertension with inhibitors of the prostaglandin transporter: evaluation of patent WO2014/204895A1. Expert Opinion on Therapeutic Patents. 25(9). 1069–1077. 1 indexed citations
7.
Treiber, Alexander, et al.. (2015). The metabolism of the dual endothelin receptor antagonist macitentan in rat and dog. Xenobiotica. 46(3). 253–267. 5 indexed citations
8.
Gatfield, John, Catherine Roch, Alexander Treiber, et al.. (2015). Discovery and optimisation of 1-acyl-2-benzylpyrrolidines as potent dual orexin receptor antagonists. MedChemComm. 6(6). 1054–1064. 5 indexed citations
9.
Bolli, Martin H., Stefan Abele, Magdalena Birker, et al.. (2013). Novel S1P1 Receptor Agonists – Part 1: From Pyrazoles to Thiophenes. Journal of Medicinal Chemistry. 56(23). 9737–9755. 18 indexed citations
10.
Schmidt, G., Stefan O. Reber, Martin H. Bolli, & Stefan Abele. (2012). Practical and Scalable Synthesis of S1P1 Receptor Agonist ACT-209905. Organic Process Research & Development. 16(4). 595–604. 16 indexed citations
11.
Piali, Luca, Sylvie Froidevaux, Patrick Hess, et al.. (2011). The Selective Sphingosine 1-Phosphate Receptor 1 Agonist Ponesimod Protects against Lymphocyte-Mediated Tissue Inflammation. Journal of Pharmacology and Experimental Therapeutics. 337(2). 547–556. 89 indexed citations
12.
Iglarz, Marc, Christoph A. Binkert, Keith Morrison, et al.. (2008). Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 327(3). 736–745. 260 indexed citations
13.
Pallan, Pradeep S., Paolo Lubini, Martin H. Bolli, & Martin Egli. (2007). Backbone-base inclination as a fundamental determinant of nucleic acid self- and cross-pairing. Nucleic Acids Research. 35(19). 6611–6624. 33 indexed citations
14.
Bolli, Martin H., Christoph Boss, Martine Clozel, et al.. (2003). The use of sulfonylamido pyrimidines incorporating an unsaturated side chain as endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(5). 955–959. 9 indexed citations
15.
Micura, Ronald, Martin H. Bolli, Norbert Windhab, & Albert Eschenmoser. (1997). Auch Pyranosyl‐RNA bildet Haarnadel‐Strukturen. Angewandte Chemie. 109(8). 899–902. 10 indexed citations
16.
17.
Bolli, Martin H.. (1996). Watson-Crick base-pairing properties of bicyclo-DNA. Nucleic Acids Research. 24(23). 4660–4667. 53 indexed citations
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangshu Xiao Breakdown of academic impact, for papers by Jan Rosing Breakdown of academic impact, for papers by W. Schöner Breakdown of academic impact, for papers by Kazuki Sakata Breakdown of academic impact, for papers by Rozalina Grubina Breakdown of academic impact, for papers by G. Bernhardt Breakdown of academic impact, for papers by Mark S. Lowenthal Breakdown of academic impact, for papers by Glenn C. Andrews Breakdown of academic impact, for papers by Robert J. Rutman Breakdown of academic impact, for papers by Hitoshi Fujita
Rankless by CCL
2026